These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 37005166)
1. The Confusion Surrounding Androgen Deprivation Therapy and Cognitive Dysfunction. Pierro MJ; Kilari D Eur Urol Focus; 2023 May; 9(3):409-410. PubMed ID: 37005166 [TBL] [Abstract][Full Text] [Related]
2. Androgen-deprivation therapy, dementia, and cognitive dysfunction in men with prostate cancer: How much smoke and how much fire? McHugh DJ; Root JC; Nelson CJ; Morris MJ Cancer; 2018 Apr; 124(7):1326-1334. PubMed ID: 29338083 [TBL] [Abstract][Full Text] [Related]
3. The impact of long-term androgen deprivation therapy on cognitive function and socioeconomic decision making in prostate cancer patients. Holtfrerich SKC; Knipper S; Purwins J; Castens J; Beyer B; Schlomm T; Diekhof EK Psychooncology; 2020 Aug; 29(8):1338-1346. PubMed ID: 32539186 [TBL] [Abstract][Full Text] [Related]
4. Risks associated with cognitive function and management strategies in the clinical use of ADT: a systematic review from clinical and preclinical studies. Cui MF; Chen LM; Jiang C; Ma BZ; Yuan FW; Zhao C; Liu SM Support Care Cancer; 2024 Jul; 32(8):561. PubMed ID: 39085696 [TBL] [Abstract][Full Text] [Related]
5. Different androgen deprivation therapies might have a differential impact on cognition - An analysis from a population-based study using time-dependent exposure model. Hong JH; Huang CY; Chang CH; Muo CH; Jaw FS; Lu YC; Chung CJ Cancer Epidemiol; 2020 Feb; 64():101657. PubMed ID: 31918180 [TBL] [Abstract][Full Text] [Related]
6. Prostate cancer treatment and the relationship of androgen deprivation therapy to cognitive function. Reiss AB; Saeedullah U; Grossfeld DJ; Glass AD; Pinkhasov A; Katz AE Clin Transl Oncol; 2022 May; 24(5):733-741. PubMed ID: 34743290 [TBL] [Abstract][Full Text] [Related]
7. Ligand-gated ion channels as potential biomarkers for ADT-mediated cognitive decline in prostate cancer patients. Verma S; Singh V; Nagampalli V; Ponsky LE; Li CR; Chao H; Gupta S Mol Carcinog; 2024 Jun; 63(6):1051-1063. PubMed ID: 38482990 [TBL] [Abstract][Full Text] [Related]
8. Cognitive decline in prostate cancer patients undergoing ADT: a potential role for exercise training. Mundell NL; Daly RM; Macpherson H; Fraser SF Endocr Relat Cancer; 2017 Apr; 24(4):R145-R155. PubMed ID: 28209634 [TBL] [Abstract][Full Text] [Related]
9. Cognitive Impairment in Men with Prostate Cancer Treated with Androgen Deprivation Therapy: A Systematic Review and Meta-Analysis. Sun M; Cole AP; Hanna N; Mucci LA; Berry DL; Basaria S; Ahern DK; Kibel AS; Choueiri TK; Trinh QD J Urol; 2018 Jun; 199(6):1417-1425. PubMed ID: 29410294 [TBL] [Abstract][Full Text] [Related]
10. Correlation of Androgen Deprivation Therapy with Cognitive Dysfunction in Patients with Prostate Cancer: A Nationwide Population-Based Study Using the National Health Insurance Service Database. Tae BS; Jeon BJ; Shin SH; Choi H; Bae JH; Park JY Cancer Res Treat; 2019 Apr; 51(2):593-602. PubMed ID: 30025445 [TBL] [Abstract][Full Text] [Related]
11. Androgen deprivation therapy and cognitive decline-associations with brain connectomes, endocrine status, and risk genotypes. Buskbjerg CR; Amidi A; Buus S; Gravholt CH; Hadi Hosseini SM; Zachariae R Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):208-218. PubMed ID: 34088994 [TBL] [Abstract][Full Text] [Related]
12. Effects of vortioxetine on hippocampal-related cognitive impairment induced in rats by androgen deprivation as a model of prostate cancer treatment. Vaiana AM; Chen Y; Gelfond J; Johnson-Pais TL; Leach RJ; Ramamurthy C; Thompson IM; Morilak DA Transl Psychiatry; 2023 Oct; 13(1):307. PubMed ID: 37788996 [TBL] [Abstract][Full Text] [Related]
13. Androgen-deprivation therapy and cognitive decline in the NEON-PC prospective study during the COVID-19 pandemic. Araújo N; Costa A; Lopes-Conceição L; Ferreira A; Carneiro F; Oliveira J; Braga I; Morais S; Pacheco-Figueiredo L; Ruano L; Cruz VT; Pereira S; Lunet N ESMO Open; 2022 Apr; 7(2):100448. PubMed ID: 35344749 [TBL] [Abstract][Full Text] [Related]
14. Effects of androgen deprivation on cerebral morphometry in prostate cancer patients--an exploratory study. Chao HH; Hu S; Ide JS; Uchio E; Zhang S; Rose M; Concato J; Li CS PLoS One; 2013; 8(8):e72032. PubMed ID: 23977199 [TBL] [Abstract][Full Text] [Related]
15. Neuropsychiatric Impact of Androgen Deprivation Therapy in Patients with Prostate Cancer: Current Evidence and Recommendations for the Clinician. Siebert AL; Lapping-Carr L; Morgans AK Eur Urol Focus; 2020 Nov; 6(6):1170-1179. PubMed ID: 32690473 [TBL] [Abstract][Full Text] [Related]
16. Androgen Deprivation Therapy and Mental Health: Impact on Depression and Cognition. Izard JP; Siemens DR Eur Urol Focus; 2020 Nov; 6(6):1162-1164. PubMed ID: 31911085 [TBL] [Abstract][Full Text] [Related]
17. Androgen deprivation therapy and the risk of coronary heart disease and heart failure in patients with prostate cancer: a nested case-control study in UK primary care. Martín-Merino E; Johansson S; Morris T; García Rodríguez LA Drug Saf; 2011 Nov; 34(11):1061-77. PubMed ID: 21981434 [TBL] [Abstract][Full Text] [Related]
18. Impact of androgen-deprivation therapy on cognitive function in men with nonmetastatic prostate cancer. Alibhai SM; Breunis H; Timilshina N; Marzouk S; Stewart D; Tannock I; Naglie G; Tomlinson G; Fleshner N; Krahn M; Warde P; Canning SD J Clin Oncol; 2010 Dec; 28(34):5030-7. PubMed ID: 21041708 [TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive environment in response to androgen deprivation treatment in prostate cancer. Qin C; Wang J; Du Y; Xu T Front Endocrinol (Lausanne); 2022; 13():1055826. PubMed ID: 36506053 [TBL] [Abstract][Full Text] [Related]
20. Androgen Deprivation Therapy and Cognitive Function in Prostate Cancer. Kluger J; Roy A; Chao HH Curr Oncol Rep; 2020 Feb; 22(3):24. PubMed ID: 32048059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]